Similar organisations to Society of Urologic Oncology Clinical Trials Consortium
-
Cancer
-
37.
American Bladder Cancer Society Inc
Join us on Facebook and our online support community www.
6100
Dalton
Campaign to Save Lives
Cancer program at Northwestern Memorial Hospital, among the top-ranked in U.
14472
Highland Park
-
Single Organization Support
-
39.
Ecog-Acrin Medical Research Foundation Inc
Biomarker-driven medical research involving adults who have or are at risk of developing cancer Biomarker-driven research involving adults who have or are at risk of developing cancer THE PURPOSE OF ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.
6819
Philadelphia
-
Diseases of Specific Organs
-
40.
Minnesota Prostate Cancer Coalition
MNPCC About the MN Prostate Cancer Coalition MNPCC During a man39s lifetime one in seven will be diagnosed with prostate cancer.
Minneapolis
Gateway for Cancer Research Inc.
A not-for-profit 501 (c)(3) organization that supports innovative, groundbreaking clinical trials to conquer cancer TODAY.
10383
Schaumburg
-
Cancer
-
42.
Arizona Prostate Cancer Coalition Inc
The Arizona Prostate Cancer Coalition is an inclusive statewide organization promoting awareness, education, early detection, effective treatment, and support for prostate cancer patients, their families and caregivers.
Gilbert
-
Promotion of Business (Chambers of Commerce)
-
43.
ALLIANCE OF DEDICATED CANCER CENTERS INC
Our Impact The Alliance of Dedicated Cancer Centers ADCC is made up of Americas leading cancer centers.
HOUSTON
-
Public Foundations
-
44.
PETER MICHAEL FOUNDATION
Supporting Visionary Prostate Cancer Research Peter Michael Foundation contributes significantly to prostate cancer patient care and the identificationtreatment and management of the disease learn more Peter Michael Foundation Home Page Immunotherapy Prostate Cancer Peter Michael Foundation Events PMW Promo 2020 from Cineteller Productions.
857
CALISTOGA
-
Cancer Research
-
45.
TargetCancer Foundation Inc
TargetCancer Foundation (TCF) works to advance the development of more effective & personalized treatments for people with rare cancers.
2076
Cambridge




